14. Radiation Therapy Oncology Group. A phase Ⅱ study of concurrent chemoradiotherapy using three-dimensional conformal radiotherapy (3D-CRT) or intensity-modulated radiation therapy (IMRT)+Bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer: RTOG 0615 [R/OL]. (2014-11-25) [2016-05-24]. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0615.
[3]
15. Radiation Therapy Oncology Group. A phase Ⅱ study of intensity modulated radiation therapy (IMRT) +/- chemotherapy for nasopharyngeal cancer: RTOG 0225[R/OL]. (2005-05-26) [2016-05-24]. http://rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0225.
[4]
16. Boggula R, Lorenz F, Mueller L, et al. Experimental validation of a commercial 3D dose verification system for intensity-modulated arc therapies. Phys Med Biol, 2010, 55(19): 5619-5633.
[5]
17. Sun Ying, Guo Rui, Yin Wenjing, et al. Which T category of nasopharyngeal carcinoma may benefit most from volumetric modulated arc therapy compared with step and shoot intensity modulated radiation therapy. PLoS One, 2013, 8(9): e75304.
[6]
18. Lu S H, Cheng J C, Kuo S H, et al. Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT. Radiother Oncol, 2012, 104(3): 324-330.
[7]
19. Kan M W, Wong W, Leung L H, et al. A comprehensive dosimetric evaluation of using RapidArc volumetric-modulated arc therapy for the treatment of early-stage nasopharyngeal carcinoma. J Appl Clin Med Phys, 2012, 13(6): 3887.
[8]
1. Nutting C M, Morden J P, Harrington K J, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol, 2011, 12(2): 127-136.
[9]
2. Veldeman L, Madani I, Hulstaert F, et al. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol, 2008, 9(4): 367-375.
[10]
3. Tribius S, Bergelt C. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev, 2011, 37(7): 511-519.
[11]
4. Lai S Z, Li W F, Chen L, et al. How dose intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys, 2011, 80: 661-668.
[12]
5. Peng Gang, Wang Tao, Yang Kunyu, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol, 2012, 104(3): 286-293.
[13]
6. Palma D, Vollans E, James K, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys, 2008, 72(4): 996-1001.
[14]
7. Yin Li, Wu Hao, Gong Jian, et al. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison. World J Gastroenterol, 2012, 18(37): 5266-5275.
[15]
8. Dai Xiaofang, Zhao Yingchao, Liang Zhiwen, et al. Volumetric-modulated arc therapy for oropharyngeal carcinoma: a dosimetric and delivery efficiency comparison with static-field IMRT. Phys Med, 2015, 31(1): 54-59.
[16]
9. Holt A, Van Gestel D, Arends M P, et al. Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head-and-neck cancer: a planning study. Radiat Oncol, 2013, 8: 26.
[17]
10. Stieler F, Wolff D, Schmid H, et al. A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT. Radiother Oncol, 2011, 101(3): 388-393.
[18]
11. Ning Zhonghua, Mu Jinming, Jin Jianxue, et al. Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy. Radiat Oncol, 2013, 8: 237.
[19]
12. Lee T F, Ting H M, Chao P J, et al. Dual arc volumetric-modulated arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT. Clin Oncol, 2012, 24(3): 196-207.
